The primary outcome of death or new myocardial
infarction through day 7 occurred in 5.5 percent of the patients treated with otamixaban vs. 5.7 percent of the patients treated with UFH plus eptifibatide.
Not exact matches
The patients were followed up
through provincial health administrative data (Ontario, Canada) until May 2011 for CV disease (myocardial
infarction, stroke, congestive heart failure, revascularization procedures) and death from any cause, analyzed as a composite outcome.
Most of these deaths in young women are caused by myocardial
infarction [heart attack] which is largely preventable
through modification of risk factors,» he points out.
These findings suggest that frequent blood loss
through voluntary blood donations may be associated with a reduced risk of acute myocardial
infarction in middle - aged men.